Metformin Derivative HL156A Reverses Multidrug Resistance by Inhibiting HOXC6/ERK1/2 Signaling in Multidrug-Resistant Human Cancer Cells

• Үндсэн зохиолчид: Yun Soo Jeong (Зохиогч), Thuy Giang Lam (Зохиогч), Seho Jeong (Зохиогч), Sang-Gun Ahn (Зохиогч)
• Формат: Ном
• Хэвлэсэн: MDPI AG, 2020-08-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Multidrug resistance is a significant clinical crisis in cancer treatment and has been linked to the cellular expression of multidrug efflux transporters. The aim of this study was to examine the effects and mechanisms of the metformin derivative HL156A on human multidrug resistance (MDR) cancer cel...